B M Kerr
About
In The Last Decade
B M Kerr
15 papers receiving 327 citations
Peers
Comparison fields: 5 of 76
- Pediatrics, Perinatology and Child Health 145
- Oncology 117
- Pharmacology 83
- Surgery 79
- Psychiatry and Mental health 57
Countries citing papers authored by B M Kerr
This map shows the geographic impact of B M Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B M Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B M Kerr more than expected).
Fields of papers citing papers by B M Kerr
This network shows the impact of papers produced by B M Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B M Kerr. The network helps show where B M Kerr may publish in the future.
Co-authorship network of co-authors of B M Kerr
This figure shows the co-authorship network connecting the top 25 collaborators of B M Kerr. A scholar is included among the top collaborators of B M Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B M Kerr. B M Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | The pharmacokinetics of nelfinavir administered alone and with rifampin in healthy volunteers | 4 |
| 5 | Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans. | 16 |
| 6 | 12 | |
| 7 | Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918. | 56 |
| 8 | 120 | |
| 9 | 24 | |
| 10 | 12 | |
| 11 | Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis. | 50 |
| 12 | 13 | |
| 13 | 7 | |
| 14 | Chemical aspects of propranolol metabolism. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)propane-1,2-diol as a metabolite of propranolol in the dog, in man and in the rat liver 9000g supernatant fraction. | 1 |
| 15 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.